Exmceuticals Inc banner
E

Exmceuticals Inc
CNSX:EXM

Watchlist Manager
Exmceuticals Inc
CNSX:EXM
Watchlist
Price: 0.2 CAD Market Closed
Market Cap: CA$15m

Exmceuticals Inc
Long-Term Debt

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Exmceuticals Inc
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
E
Exmceuticals Inc
CNSX:EXM
Long-Term Debt
CA$310k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bausch Health Companies Inc
TSX:BHC
Long-Term Debt
$20.6B
CAGR 3-Years
0%
CAGR 5-Years
-3%
CAGR 10-Years
-4%
Canopy Growth Corp
TSX:WEED
Long-Term Debt
CA$242.3m
CAGR 3-Years
-34%
CAGR 5-Years
-20%
CAGR 10-Years
52%
Cronos Group Inc
TSX:CRON
Long-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Long-Term Debt
$40.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
K
Knight Therapeutics Inc
TSX:GUD
Long-Term Debt
CA$57.8m
CAGR 3-Years
0%
CAGR 5-Years
87%
CAGR 10-Years
N/A
No Stocks Found

Exmceuticals Inc
Glance View

Market Cap
15m CAD
Industry
Pharmaceuticals

EXMceuticals, Inc. is a pharmaceutical biosciences company, which engages in producing therapeutic cannabis. The company is headquartered in Calgary, Alberta. The company went IPO on 2019-01-31. The firm operates through its geographic segments, which include Canada, Portugal, Uganda and Netherlands. The Company’s subsidiaries include EXMceuticals Inc., EXMceuticals Holdings B.V, EXMceuticals Portugal, LDA and EXMceuticals Portugal II, Unipessoal Lda.

EXM Intrinsic Value
Not Available
E

See Also

What is Exmceuticals Inc's Long-Term Debt?
Long-Term Debt
310k CAD

Based on the financial report for Jun 30, 2020, Exmceuticals Inc's Long-Term Debt amounts to 310k CAD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett